AVEO Pharmaceuticals AVEO
$ 15.0
0.0%
Quarterly report 2022-Q3
added 11-07-2022
Country |
USA |
IPO year |
2010 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
CEO |
Mr. Michael Bailey |
Employees in the company |
19 |
Shares |
32.7 M |
Market Cap[1] |
$ 521 M |
EBITDA (LTM) |
$ -26.4 M |
P/E (LTM) |
-16.67 |
P/S (LTM) |
6.19 |
EPS (LTM) |
-0.9 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.